O24.4 Gestational diabetes mellitus

Name of the Condition

• Gestational diabetes mellitus (O24.4)

Summary

This condition refers to glucose intolerance that is first recognized during pregnancy and is not overt diabetes prior to gestation. It typically develops in the second or third trimester due to hormonal changes that increase insulin resistance. Management focuses on controlling blood glucose levels to reduce risks to the mother and fetus.

Causes

Gestational diabetes occurs when pregnancy-related hormones (e.g., human placental lactogen, progesterone) impair insulin sensitivity, overwhelming the pancreas’ ability to produce sufficient insulin. Risk increases as pregnancy progresses, particularly in the second and third trimesters, when insulin resistance peaks.

Risk Factors

• Obesity (BMI ≥30) or excessive weight gain before pregnancy.
• Advanced maternal age (≥35 years).
• Family history of type 2 diabetes.
• Previous gestational diabetes in a prior pregnancy.
• Polycystic ovary syndrome (PCOS).
• Ethnicity (higher prevalence in Hispanic, African American, Asian, or Native American populations).
• History of delivering a large-for-gestational-age infant or unexplained stillbirth.

Symptoms

• Increased thirst (polydipsia) and urination (polyuria).
• Fatigue.
• Blurred vision.
• Recurrent infections (e.g., yeast infections).
• Nausea or vomiting (may overlap with pregnancy symptoms).

Diagnosis

Diagnosis typically involves screening between 24–28 weeks of gestation using a glucose challenge test followed by a glucose tolerance test if results are abnormal. Criteria include elevated fasting or postprandial glucose levels meeting specific thresholds. Documentation should specify timing relative to pregnancy (e.g., trimester) and whether the condition is new or persistent.

Treatment Options

Management includes dietary modifications, regular physical activity, and blood glucose monitoring. If lifestyle changes are insufficient, insulin or oral hypoglycemic agents may be prescribed. Treatment plans are tailored to maintain fasting and postprandial glucose within target ranges to minimize complications.

Prognosis and Follow-Up

Most cases resolve after delivery, but affected individuals have an increased risk of developing type 2 diabetes later in life. Postpartum glucose testing (typically 6–12 weeks) is recommended to confirm resolution. Long-term follow-up includes regular screening for diabetes and cardiovascular risk factors.

Complications

• Maternal: Preeclampsia, cesarean delivery, future type 2 diabetes.
• Fetal: Macrosomia (large birth weight), birth injury, neonatal hypoglycemia, respiratory distress syndrome.

Lifestyle & Prevention

• Maintain a balanced diet with controlled carbohydrate intake.
• Engage in regular moderate exercise (e.g., walking) as advised by a healthcare provider.
• Achieve a healthy pre-pregnancy weight and limit excessive weight gain during pregnancy.
• Monitor blood glucose levels as directed.

When to Seek Professional Help

Seek care if experiencing symptoms like excessive thirst, frequent urination, or unexplained fatigue. Immediate medical attention is needed for signs of hyperglycemia (e.g., confusion, rapid breathing) or hypoglycemia (e.g., dizziness, sweating).

Tips for Medical Coders

Document the timing of diagnosis (e.g., trimester) and whether the condition is new or persistent. Ensure documentation supports the use of O24.4 by confirming glucose intolerance first recognized during pregnancy. Include details on management (e.g., dietary, pharmacologic) and follow-up testing if available, as these may influence coding specificity.